Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Daniela Cristina Stefan"'
Autor:
Daniela Cristina Stefan
Publikováno v:
Infectious Agents and Cancer, Vol 14, Iss 1, Pp 1-2 (2019)
Abstract The WHO Global Initiative for Childhood Cancer launched in 2018 will translate into an additional one million lives saved or a survival rate of at least 60% for children with cancer to be attained by 2030. This new target represents a doubli
Externí odkaz:
https://doaj.org/article/ec678666467d42488864b14320c6bd9a
Autor:
Daniela Cristina Stefan
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-2 (2017)
Externí odkaz:
https://doaj.org/article/34d0ddeb62d14d44b2f513cd14692f69
Publikováno v:
The Pan African Medical Journal, Vol 21, Iss 326 (2015)
INTRODUCTION: Wilms tumor (WT) or nephroblastoma is the commonest childhood cancer in Rwanda.Nephroblastoma is regarded as one of the successes of pediatric oncology with long-term survival approaching 90%. The Objectives to evaluate the feasibilityo
Externí odkaz:
https://doaj.org/article/ed3ee0e51673421d9dc76e851a914685
Publikováno v:
The Pan African Medical Journal, Vol 17, Iss 191 (2014)
INTRODUCTION: Childhood cancer is rare and comprises only 1% of all cancers. The current incidence of childhood cancer in Namibia, as in many other African countries, is not known. The aim of this research was to assess the paediatric cancer incidenc
Externí odkaz:
https://doaj.org/article/d0cb8ab1aff64688b4075ae7b4242d44
Pelvic Exenteration in Advanced, Recurrent or Synchronous Cancers—Last Resort or Therapeutic Option?
Autor:
Vlad Rotaru, Elena Chitoran, Daniela-Luminita Zob, Sinziana-Octavia Ionescu, Gelal Aisa, Prie Andra-Delia, Dragos Serban, Daniela-Cristina Stefan, Laurentiu Simion
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1707 (2024)
First described some 80 years ago, pelvic exenteration remain controversial interventions with variable results and ever-changing indications. The previous studies are not homogenous and have different inclusion criteria (different populations and di
Externí odkaz:
https://doaj.org/article/df3d08cb080a42ef882e8ee1ff100334
Autor:
Laurentiu Simion, Ina Petrescu, Elena Chitoran, Vlad Rotaru, Ciprian Cirimbei, Sinziana-Octavia Ionescu, Daniela-Cristina Stefan, Dan Luca, Dana Lucia Stanculeanu, Adelina Silvana Gheorghe, Horia Doran, Ioana Mihaela Dogaru
Publikováno v:
Life, Vol 14, Iss 1, p 138 (2024)
(1) Importance of problem: Breast cancer accounted for 685,000 deaths globally in 2020, and half of all cases occur in women with no specific risk factor besides gender and age group. During the last four decades, we have seen a 40% reduction in age-
Externí odkaz:
https://doaj.org/article/720c1294cd5c4a159b93c0f537394cfb
Autor:
Laurentiu Simion, Vlad Rotaru, Ciprian Cirimbei, Laurentia Gales, Daniela-Cristina Stefan, Sinziana-Octavia Ionescu, Dan Luca, Horia Doran, Elena Chitoran
Publikováno v:
Diagnostics, Vol 13, Iss 17, p 2776 (2023)
(1) Introduction: A Romanian woman is diagnosed with cervical cancer every two hours; the country ranks second in Europe in terms of the mortality and incidence rate of this disease. This paper aims to identify the main reasons that have led to this
Externí odkaz:
https://doaj.org/article/b3c4617a9e634831b902a7063b40e472
Autor:
Laurentiu Simion, Elena Chitoran, Ciprian Cirimbei, Daniela-Cristina Stefan, Ariana Neicu, Bogdan Tanase, Sinziana Octavia Ionescu, Dan Cristian Luca, Laurentia Gales, Adelina Silvana Gheorghe, Dana Lucia Stanculeanu, Vlad Rotaru
Publikováno v:
Diagnostics, Vol 13, Iss 12, p 2069 (2023)
The aim of our study is to present the particularities of a specific subset of gynecological cancer patients in Romania. We present a review of synchronous gynecological neoplasia (SGN) treated in the Bucharest Oncological Institute’s surgery depar
Externí odkaz:
https://doaj.org/article/c298c0cde0c74ecab12606d5f92fff8a
Autor:
Laurentiu Simion, Vlad Rotaru, Ciprian Cirimbei, Daniela-Cristina Stefan, Mirela Gherghe, Sinziana Ionescu, Bogdan Cosmin Tanase, Dan Cristian Luca, Laurentia Nicoleta Gales, Elena Chitoran
Publikováno v:
Diagnostics, Vol 13, Iss 6, p 1040 (2023)
(1) Background: Among new anti-angiogenesis agents being developed and ever-changing guidelines indications, the question of the benefits/safety ratio remains unclear. (2) Methods: We performed a systematic review combined with a meta-analysis of 23
Externí odkaz:
https://doaj.org/article/3fc3d4ea5c924328a0b0db9130dbc59d